Research graph

References

References from Structured Symptom Monitoring During Enfortumab Vedotin Plus Pembrolizumab for Advanced or Metastatic Urothelial Carcinoma: Multicenter Retrospective Study. Local targets link to admitted publications; unresolved targets remain external evidence.

No reference evidence is available for this admitted work.